INIS
antibiotics
100%
kazakhstan
81%
policy
44%
asia
37%
surveillance
28%
reviews
28%
populations
24%
humans
24%
hospitals
22%
covid-19
22%
data
16%
implementation
16%
doses
15%
surveys
13%
guidelines
13%
evaluation
12%
attitudes
12%
optimization
12%
public health
11%
modeling
11%
time-series analysis
10%
income
9%
diseases
8%
monitoring
8%
communities
7%
patients
7%
sales
6%
levels
6%
research programs
6%
expenditures
6%
influenza
6%
resources
6%
growth
6%
coronaviruses
6%
allocations
6%
consumption rates
6%
kyrgyzstan
5%
russian federation
5%
classification
5%
Keyphrases
Kazakhstan
37%
Antimicrobial Resistance
37%
Antibiotic Use
26%
Evidence-based Policy
24%
Antibiotic Stewardship
24%
Evidence-based Practice
24%
Central Asia
24%
Consumption Trends
12%
Knowledge Attitude
12%
Antiprotozoal Agents
12%
Knowledge Practices
12%
Antiprotozoal
12%
Antifungal Agents
12%
Point Prevalence Survey
12%
Personal Healthcare
12%
Antibiotics
7%
Defined Daily Dose
7%
Average Annual Percent Change
7%
Collaborative Research
6%
Antiherpes
6%
Policy Allocation
6%
Anti-influenza Agents
6%